Journal of Natural Products
Article
→ 99:1) to afford either 3a (endo-A) (from 1a, 90%) or 3b (endo-B)
(from 1b, 78%).
which was also applied to macrocarpal B (1b). Reaction
conditions were further adjusted to reverse the selectivity of the
dehydration process and permit access to macrocarpal
analogues bearing a Δ7,8 endo-double bond. Three hitherto
unknown semisynthetic derivatives of macrocarpals, i.e.,
compounds 2b, 3a, and 3b, were hence synthesized.
Compound 3a: [α]20D −20.5 (c 0.06, EtOH); IR (neat) νmax 2924,
1622, 1454, 1376, 1308, 1185 cm−1; 1H NMR (methanol-d4, 400
MHz) δ 0.55 (1H, m, H-4), 0.68−0.76 (4H, m, H-12 and H-2), 0.81
(3H, d, J = 5.9 Hz, H-4′), 0.82 (3H, d, J = 5.8 Hz, H-4′), 1.05 (3H, s,
H-13), 1.06 (3H, s, H-14), 1.10−1.22 (2H, m, H-2′ and H-3′), 1.41−
1.50 (2H, m, H-10 and H-5), 1.52 (3H, s, H-15), 1.72 (1H, m, H-5),
1.85 (1H, m, H-10), 2.10−2.31 (4H, m, H-6 and H-9), 2.34 (1H, m,
H-2′), 2.51 (1H, brs, H-1), 3.50 (1H, dd, J = 5.1 Hz, 14.6 Hz, H-1′),
10.11 (1H, s, H-22), 10.12 (1H, s, H-23); 13C NMR (methanol-d4,
100 MHz) δ 16.8, 20.0, 21.9, 22.2, 22.3, 24.2, 24.9, 27.4, 28.3, 29.1,
30.3, 31.5, 35.3, 35.7, 36.9, 37.2, 45.8, 49.7, 106.0, 106.1, 111.2, 126.7,
138.4, 168.6, 170.3, 171.0, 192.9, 193.1; negative HRESMS m/z
453.2637 (calcd for C28H37O5, 453.2641 [M − H]−).
EXPERIMENTAL SECTION
■
General Experimental Procedures. Optical rotations were
determined using the sodium D line (589 nm) on a Perkin-Elmer
341 polarimeter. IR spectra were recorded on a Perkin-Elmer System
1
2000 FT-IR. H and 13C NMR spectra were recorded on a Bruker
Avance DPX 400 spectrometer at 400 and 100 MHz, respectively.
Chemical shifts (δ) are expressed in ppm, and coupling constant (J) in
hertz. Chemicals were purchased from Aldrich. Reactions were carried
out using dry solvents. THF was distilled from sodium/benzophenone.
Flash chromatography was carried out on Kieselgel 60 (230−240
mesh, Merck), and analytical TLC was performed on Merck precoated
silica gel (60 F254); visualization was done with UV and/or heating
with a solution of 5−7% phosphomolybdic acid in EtOH. HRMS
Compound 3b: [α]20 +47.1 (c 0.1, EtOH); IR (neat) νmax 2924,
D
1623, 1452, 1376, 1308, 1184 cm−1; 1H NMR (methanol-d4, 400
MHz) δ 0.56 (1H, m, H-4), 0.76 0.84 (4H, m, H-2 and H-4′), 0.86
(3H, d, J = 6.4 Hz, H-4′), 1.05 (3H, s, H-12), 1.06 (3H, s, H-13), 1.07
(1H, m, H-10), 1.17 (3H, s, H-14), 1.22 (1H, m, H-3′), 1.33−1.42
(2H, m, H-2′ and H-10), 1.52 (3H, s, H-15), 1.55 (1H, m, H-5), 1.73
(1H, m, H-5), 2.07−2.24 (4H, m, H-6 and H-9), 2.38 (1H, td, J =
12.9, 3.2 Hz, H-2′), 2.44 (1H, m, H-1), 3.32 (1H, dd, J = 13.1, 3.9 Hz,
H-1′), 10.10 (1H, s, H-22), 10.12 (1H, s, H-23); 13C NMR
(methanol-d4, 100 MHz) δ 15.1, 17.5, 18.2, 19.2, 20.9, 22.6, 23.5,
26.0, 26.7, 27.7, 29.7, 30.3, 35.6, 35.7, 37.1, 40.4, 48.9, 49.1, 104.5,
104.6, 109.9, 125.4, 138.3, 166.9, 168.7, 169.5, 191.5, 191.6; negative
HRESMS m/z 453.2634 (calcd for C28H37O5, 453.2641 [M − H]−).
́
spectra were recorded at “Service de Spectrometrie de Masse de
l’Institut de Chimie des Substances Naturelles” in Gif-sur-Yvette
(France).
General Procedure for exo-Dehydration of 1a or 1b. Under
N2, macrocarpal (1a or 1b, 100 mg, 0.212 mmol, 1 equiv) was
dissolved in anhydrous THF (10 mL) before T3P (1 mL of a 50%
solution in EtOAc, 8 equiv) and DTBPyr (380 μL, 8 equiv) were
added. The reaction mixture was heated at reflux for 6 h. It was then
quenched with 1 M HCl (8 mL), and Et2O (8 mL) was added. The
organic phase was collected, and the aqueous layer was extracted with
Et2O (2 × 8 mL). The combined organic layers were washed with
brine (5 mL), dried over Na2SO4, filtered, and concentrated under
vacuum. The crude residue was purified over silica (CH2Cl2/HOAc,
99.9:0.1 → 97:3) to give 2a (from 1a, 87%) or 2b (from 1b, 89%).
Compound 2a (macrocarpal C): [α]20D −25.8 (c 0.1, EtOH); IR
(neat) νmax 3204, 2952, 2867, 1627, 1446, 1307, 1185 cm−1; 1H NMR
(methanol-d4, 400 MHz) δ 0.62−0.72 (2H, m, H-4 and H-2), 0.78
(3H, d, J = 6.2 Hz, H-4′), 0.80 (3H, d, J = 6.2 Hz, H-4′), 0.81 (3H, s,
H-12), 0.95 (1H, m, H-5), 1.01 (3H, s, H-14), 1.09 (3H, s, H-13),
1.18−1.23 (2H, m, H-3′ and H-2′), 1.30−1.43 (2H, m, H-10 and H-
1), 1.67 (1H, m, H-9), 1.79 (1H, m, H-9), 1.96−2.08 (2H, m, H-6 and
H-5), 2.22−2.47 (4H, m, H-8, H-6, H-10 and H-2′), 3.40 (1H, dd, J =
3.6 Hz, 12.8 Hz, H-1′), 4.64 (1H, s, H-15), 4.70 (1H, s, H-15), 10.11
(1H, s, H-22), 10.12 (1H, s, H-23); 13C NMR (methanol-d4, 100
MHz): δ 17.4, 21.0, 22.4, 23.9, 24.9, 26.8, 28.2, 28.5, 28.6, 29.3, 29.5,
36.0, 37.4, 38.7, 40.5, 50.6, 51.7, 52.5, 106.1, 106.1, 106.2, 111.3, 156.5,
168.7, 170.4, 170.9, 192.9, 193.1; negative HRESMS m/z 453.2623
(calcd for C28H37O5, 453.2641 [M − H]−).
ASSOCIATED CONTENT
■
S
* Supporting Information
Copies of 1H and 13C NMR for compounds 2a, 2b, 3a, and 3b.
This material is available free of charge via the Internet at
AUTHOR INFORMATION
Corresponding Authors
+33 169 08 84 84.
■
08 80 71.
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
J.A. thanks the CEA and “Les Laboratoires Pierre Fabre” for a
CTCI Ph.D. grant. The “Service de Chimie Bioorganique et de
Marquage” belongs to the Laboratory of Excellence in Research
on Medication and Innovative Therapeutics (LabEx LERMIT).
Compound 2b: [α]20 +9.8 (c 0.1, EtOH); IR (neat) νmax 3423,
D
2951, 2864, 1632, 1446, 1305, 1179 cm−1; 1H NMR (methanol-d4, 400
MHz) δ 0.62−0.83 (5H, m, H-4, H-2 and H-4′),0.85 (3H, d, J = 6.5
Hz, H-4′), 1.00 (1H, m, H-5), 1.10−1.25 (11H, m, H-13, H-14, H-10,
H-12, and H-3′), 1.27−1.40 (2H, m, H-1 and H-2′), 1.55 (1H, m, H-
9), 1.63 (1H, m, H-10), 1.83 (1H, m, H-9), 1.96 (1H, m, H-6), 2.04
(1H, m, H-5), 2.38 (3H, m, H-8, H-6 and H-2′), 3.33 (1H, m, H-1′),
4.62 (1H, s, H-15), 4.69 (1H, s, H-15), 10.11 (1H, s, H-22), 10.12
(1H, s, H-23); 13C NMR (methanol-d4, 100 MHz) δ 17.5, 19.8, 20.7,
21.6, 24.8, 27.1, 27.3, 28.0, 28.1, 29.4, 31.7, 36.5, 40.6, 41.1, 42.7, 51.0,
54.8, 56.4, 105.6, 106.0, 106.1, 111.5, 157.0, 168.5, 170.4, 171.0, 193.1,
193.3; negative HRESMS m/z 453.2619 (calcd for C28H37O5,
453.2641 [M − H]−).
REFERENCES
■
(1) (a) Eschler, B. M.; Pass, D. M.; Willis, R.; Foley, W. J. Biochem.
Syst. Ecol. 2000, 28, 813−824. (b) Moore, B. D.; Foley, W. J.; Wallis, I.
R.; Cowling, A.; Handasyde, K. A. Biol. Lett. 2005, 1, 64−67.
(2) Murata, M.; Yamakoshi, Y.; Homma, S.; Aida, K.; Hori, K.;
Ohashi, Y. Agric. Biol. Chem. 1990, 54, 3221−3226.
(3) Yamakoshi, Y.; Murata, M.; Shimizu, A.; Homma, S. Biosci.
Biotech. Biochem. 1992, 56, 1570−1576.
(4) Nishizawa, M.; Emura, M.; Kan, Y.; Yamada, H.; Ogawa, K.;
Hamanaka, N. Tetrahedron Lett. 1992, 33, 2983−2986.
(5) Osawa, K.; Yasuda, H. J. Nat. Prod. 1996, 59, 823−827.
(6) Ghisalberti, E. L. Phytochemistry 1996, 41, 7−22.
(7) Tanaka, T.; Mikamiyama, H.; Maeda, K.; Ishida, T.; In, Y.; Iwata,
C. Chem. Commun. 1997, 2401−2402.
(8) Tanaka, T.; Mikamiyama, H.; Maeda, K.; Iwata, C.; In, Y.; Ishida,
T. J. Org. Chem. 1998, 63, 9782−9793.
General Procedure for endo-Dehydration of 1a or 1b. Under
N2, macrocarpal (1a or 1b, 50 mg, 0.106 mmol, 1 equiv) was dissolved
in anhydrous THF (4 mL), and three drops of concentrated H2SO4
were added. After stirring for 1 h at room temperature, H2O (5 mL)
and Et2O (5 mL) were added. The aqueous layer was extracted with
Et2O (2 × 5 mL). The combined organic layer was washed with brine
(5 mL), dried over Na2SO4, filtered, and concentrated under vacuum.
The crude product was purified over silica (CH2Cl2/HOAc, 99.9:0.1
C
dx.doi.org/10.1021/np400869z | J. Nat. Prod. XXXX, XXX, XXX−XXX